DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ovrette (Norgestrel) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

OVRETTE SUMMARY

Each OVRETTE tablet contains 0.075 mg of norgestrel, a progestin-only oral contraceptive.

Progestin-only oral contraceptives are indicated for the prevention of pregnancy.
See all Ovrette indications & dosage >>

OVRETTE NEWS HIGHLIGHTS

Media Articles Related to Ovrette (Norgestrel)

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

Reuters Examines Future Agenda For Abortion Rights Supporters Under Obama Administration
Source: Abortion News From Medical News Today [2008.11.25]

more >>

Published Studies Related to Ovrette (Norgestrel)

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers. [2008.04]

Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers. [2008]

A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. [2007.12]

A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel). [2007.09]

Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. [2007.08]

more >>

Clinical Trials Related to Ovrette (Norgestrel)

Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer [Active, not recruiting]

A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA® (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST® (an Oral Contraceptive) [Completed]

A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA® (a Transdermal Contraceptive Patch) [Completed]

A Comparative Pharmacokinetic Study of ORTHO EVRA® (a Transdermal Contraceptive Patch) and CILEST® (an Oral Contraceptive) in Healthy Female Volunteers [Completed]

An Open-Label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol [Completed]

more >>

Page last updated: 2008-11-25

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008